Atlas Trials

PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer

Clinical trial NCT02423603 · COMPLETED

Trial details

NCT number
NCT02423603
Sponsor
Queen Mary University of London
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2014-05-14
Primary completion
2017-06-30
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.